Most Awaited Q3 Sale is back. Upto 30% discount on every report.

Infection Control Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 September 05
SKU : HOS1071
180 pages
Report Summary
Table of Contents
List of Tables & Figures

Infection Control Market is segmented By Product Type (Disinfection products, Sterilization Products, Packaging Accessories, Protective Barriers, Endoscope Reprocessing Products, Others), By End-User (Hospitals, Ambulatory Surgical Centers, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030 


Infection Control Market Overview

The Infection Control Market report is a comprehensive analysis of the global market size, shares, recent trends, competitive intelligence, and future market outlook. Infection control is a crucial aspect of healthcare to prevent the spread of infections in healthcare settings. The market for infection control products and solutions is driven by the increasing need for effective infection control measures, growing awareness about healthcare-associated infections (HAIs), and the rising demand for reliable infection control solutions in minimally invasive surgeries, particularly in the Asia Pacific region. Key players in the Infection Control Market include 3M Company, Johnson & Johnson Services, Inc., Procter & Gamble, and other prominent players operating in the market. 

Infections are primarily caused by microorganisms such as bacteria, viruses, and fungi. Infections can be of different types, such as Hospital Acquired Infections (HAIs), stomach and intestinal infections, eye infections, ear infections, lung and respiratory infections, skin infections, and sexually transmitted infections caused by the cross-infection from equipment, surface, and skin of patient and healthcare staff. Infection prevention and control are carried out to prevent infectious diseases. The major HAIs are ventilator-associated pneumonia, infections in the bloodstream, and catheter-associated urinary tract infection (UTIs).

Infection control market study analysis offers an in-depth outlook on the market containing quantitative and qualitative data. It gives an outlook and forecast of the global market based on market segmentation. It also provides global Infection control market size, and growth, along with the latest trends, opportunities, and forecast till 2029 for the global market with esteem to major countries such as the United States, Canada, Brazil, Germany, Italy, Spain, United Kingdom, Russia, European countries, United Arab Emirates, Saudi Arabia, South Africa, Japan, China, India, South Korea, Australia, and rest of the countries over the globe.

Among all regions, the North American region is expected to hold the largest share of the global market over the forecast period. The Infection control market in the United States and Canada produces the utmost share. Whereas the European Infection control market is projected to continue its presence globally from 2023 to 2030.

Infection Control Market Summary



Market CAGR


Segments Covered

By Product Type, By End-User, and By Region

Report Insights Covered

Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.

Fastest Growing Region

Asia Pacific

Largest Market Share 

North America


For More Insights about the Market Request Free Sample


Infection Control Market Dynamics

High incidence of HAIs, an increasing number of surgical procedures, a growing geriatric population, increasing cases of chronic diseases such as cancer, diabetes, obesity, heart, and respiratory disorders, and a growing need for food sterilization and disinfection are some of the major factors driving the growth of the market in the forecasted period.

The increasing prevalence of Hospital-acquired Infections is expected to drive market growth.

According to World Health Organization Report 2022, Hospital-acquired infections (HAIs) are diseases acquired in a hospital or other healthcare institution and manifest 48 hours or more after admission or within 30 days of discharge. Pathogens that cause hospital-acquired infection include viruses, bacteria, and fungi. Bloodstream infections (BSI), pneumonia, urinary tract infections (UTI), and surgical site infections are the most prevalent illnesses (SSI). These infections endanger the patient's health and life and lengthen hospital stays, adding to the financial burden. These infections account for around 7% and 10% of all reported infections in developed and developing nations. In acute-care hospitals, 7  patients in high-income countries and 15 in low- and middle-income countries will contract at least one healthcare-associated infection (HAI) during their stay. One in every ten affected patients would die due to their HAI.

Additionally, HAIs and antimicrobial resistance greatly impact people's lives. Every year, more than 24% of patients with health-care-associated sepsis and 52.3% of those treated in an intensive care unit die. As a result, the WHO launched IPC programs to assure the quality of treatment and the safety of patients and health staff. This will not only protect their communities but it has also been shown that increasing investment in IPC improves health outcomes and lowers healthcare costs and out-of-pocket expenses. Thus, from the above factors, the market is expected to drive in the forecast period.

Difficulties in infection surveillance are expected to hamper the market growth.

Many hospitals still utilize manual infection surveillance approaches, such as infection preventionists checking paper culture reports for probable HAIs or patient isolation treatments. These reports are frequently delayed, reducing the ability to intervene effectively in HAI cases. Manual surveillance takes a long time and has lagged in providing data that can lead to the deployment of effective prevention strategies to lower the prevalence of drug-resistant illnesses. It is quite difficult for infection preventionists to make highly detailed judgments. The consequence of disregarding a device-associated infection is less than that of overreporting an infectious occurrence. Moreover, individuals at local facilities are doubtful to examine incidents not classified as HAI, whereas those identified as infections may also be scrutinized, taking additional time. Thus, from the above factors, the market is expected to be hampered in the forecast period.

COVID-19 Impact on Infection Control Market Growth

The COVID-19 epidemic positively impacted the infection control industry. Due to the COVID-19 outbreak, there is extraordinary global demand for modern healthcare facilities, services, and infrastructure to treat sick people. Infection control goods, such as personal protective equipment, are in high demand from most countries worldwide to deal with the rise of COVID-19 patients. Healthcare workers use personal protective equipment to keep themselves and their patients from being ill and infecting others. However, with the rapidly developing COVID-19 pandemic problem, the available capacity for face masks and gowns is insufficient, and the worldwide healthcare business is experiencing a shortage of personnel. For instance, according to the World Health Organization (WHO), 89 million medical masks will be required monthly. A 40% increase in manufacturing is expected to accommodate that demand. The WHO also believes that frontline workers will require 7-10% of the world's supply of surgical masks if not more. This figure rises to 76 million for examination gloves, while international demand for goggles is at 1.6 million monthly.

Furthermore, as the COVID-19 pandemic spreads, hospital admissions are projected to rise. SSIS is determined to be the highest contributor to the overall annual cost spent on these illnesses by healthcare facilities in the United States. In the United States, the most frequent forms of HAIs cost roughly $9.8 billion annually, with Ssis accounting for 33.7% ($3.3 billion). Thus, from the above factors, the market is affected positively in the forecast period.

Infection Control Market Segment and Shares

The sterilization Products segment is expected to hold the largest market share in infection control

The sterilization products accounted for the largest market share in 2021. Due to the growing necessity to eliminate all types of microbiological life, such as viruses, fungi, spores, and bacteria, Sterile products eliminate pathogenic germs and neutralize other hazardous organisms. For instance, radiation sterilization effectively inactivates bacteria, can be utilized for packing, and protects the safety of healthcare items. Radiation sterilization and sterilizing disposable medical instruments such as surgical gloves and syringes is a cost-effective and secure form of sterilization. Moreover, the advantage of that it can sterilize pre-packaged products. Furthermore, sanitized equipment keeps delicate pivots and hinges on pricey, high-precision tools from rusting. It also decreases the breeding habitat for surviving bacteria and ensures the safety of surgical treatments. Thus, from the above factor, the market segment accounted for the largest market share in the forecast period.

Infection Control Market Geographical Share

North America region holds the largest market share in the global infection control  

North America region accounted for the largest market share in 2021. Rising in the geriatric population, increase in the prevalence of chronic diseases and HAIs, product launches, and collaboration by the market players are the factors to drive the market in the forecast period. For instance, Metrex Research, LLC. established a strategic agreement with the Association for Specialists in Infection Control and Epidemiology (APIC), the largest association for Infection Prevention and Control (IPC) professionals, on March 24, 2021. This partner program fosters long-term connections with industry partners who share the goal of lowering infection risk. This collaboration will help lower the spread of illness and improve IP education and resources. Moreover, Ecolab acquired Holchem Group in 2020 to expand its hygiene and cleaning product and service range for the food and beverage, food service, and hotel industries. Thus, from the above factors, the North American region accounted for the largest market share in the forecast period.

Infection Control Market Companies

Major key players in the market are Getinge AB, STERIS plc, Advanced Sterilization Products, 3M Company, Belimed AG, Cantel Medical Corporation, MMM Group, Matachana Group, Sotera Health LLC, and Metrex Research Corporation. In April 2022, Getinge announced that national group purchasing organization HealthTrust awarded the company an infection control contract. The HealthTrust contract allows the organization’s members to have access to Getinge’s infection control product portfolio for the first time in more than a decade.

Getinge AB


Getinge AB is a medical technology firm that designs, develops, and markets surgical, infection control, intensive care, care ergonomics, and wound care equipment and tools. Its main products are surgical tables, lights, ventilators, and anesthesia equipment; heart-lung machines with associated disposables, equipment, and instruments for cardiac surgery and vascular surgery; cardiac assist devices; patient lifting devices, hospital beds, stretchers, and couches; mattresses for treating and preventing pressure ulcers, disinfectors, sterilization equipment, documentation systems, and various other accessories. The organization also offers hospital-related services and project implementation. The corporation has manufacturing plants in France, China, Germany, Poland, Sweden, Turkey, the Netherlands, the UK, and the US. It offers its products in over 125 countries through proprietary sales firms and a network of distributors.

­Product Portfolio:

GEE Ethylene Oxide (EO) Sterilizers: EO sterilization is used on heat/moisture-sensitive products. The sterilization process allows the product to remain packed and palletized for the entire process.

  • Safe, reliable, and repeatable results
  • Protect the integrity of products and packaging
  • Faster sterilization process

The global infection control report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Buy this report
Single User
Multiple User
Enterprise User
Proceed to Buy
Request new version
What is the Projected CAGR value of the Infection Control Market?
The Infection Control Market is expected to grow at a CAGR of 4.6% during the forecasting period 2023-2030.
Which region controlled the global market during 2023-2030?
North America region Controls the Infection Control Market during 2023-2030.
Which is the fastest-growing region in the Infection Control Market?
Asia Pacific is the fastest-growing market share during the forecast period.
Who are the key players in the Infection Control Market?
Key players are Getinge AB, STERIS plc, Advanced Sterilization Products, 3M Company, Belimed AG, Cantel Medical Corporation, MMM Group, Matachana Group, Sotera Health LLC, and Metrex Research Corporation.
Related Reports

Hospital Commode Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2022 December 15
Starting from



Durable Medical Equipment Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 July 21
Starting from



Ambulance Services Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 July 24
Starting from



Medical Oxygen Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 March 21
Starting from



Hospital Supplies Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 August 08
Starting from



Disposable Hospital Supplies Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 January 19
Starting from